Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2014 1
2015 2
2016 2
2017 2
2018 4
2019 6
2020 2
Text availability
Article attribute
Article type
Publication date

Search Results

17 results
Results by year
Filters applied: . Clear all
Page 1
MicroRNAs 146a/b-5 and 425-3p and 24-3p are markers of antidepressant response and regulate MAPK/Wnt-system genes.
Lopez JP, Fiori LM, Cruceanu C, Lin R, Labonte B, Cates HM, Heller EA, Vialou V, Ku SM, Gerald C, Han MH, Foster J, Frey BN, Soares CN, Müller DJ, Farzan F, Leri F, MacQueen GM, Feilotter H, Tyryshkin K, Evans KR, Giacobbe P, Blier P, Lam RW, Milev R, Parikh SV, Rotzinger S, Strother SC, Lewis CM, Aitchison KJ, Wittenberg GM, Mechawar N, Nestler EJ, Uher R, Kennedy SH, Turecki G. Lopez JP, et al. Among authors: Tyryshkin K. Nat Commun. 2017 May 22;8:15497. doi: 10.1038/ncomms15497. Nat Commun. 2017. PMID: 28530238 Free PMC article. Clinical Trial.
Novel prognostic and predictive microRNA targets for triple-negative breast cancer.
Turashvili G, Lightbody ED, Tyryshkin K, SenGupta SK, Elliott BE, Madarnas Y, Ghaffari A, Day A, Nicol CJB. Turashvili G, et al. Among authors: Tyryshkin K. FASEB J. 2018 May 29:fj201800120R. doi: 10.1096/fj.201800120R. Online ahead of print. FASEB J. 2018. PMID: 29812973
microRNA-guided diagnostics in clinical samples.
Gustafson D, Tyryshkin K, Renwick N. Gustafson D, et al. Among authors: Tyryshkin K. Best Pract Res Clin Endocrinol Metab. 2016 Oct;30(5):563-575. doi: 10.1016/j.beem.2016.07.002. Epub 2016 Aug 1. Best Pract Res Clin Endocrinol Metab. 2016. PMID: 27923451 Free article. Review.
Evaluating gastroenteropancreatic neuroendocrine tumors through microRNA sequencing.
Panarelli N, Tyryshkin K, Wong JJM, Majewski A, Yang X, Scognamiglio T, Kim MK, Bogardus K, Tuschl T, Chen YT, Renwick N. Panarelli N, et al. Among authors: Tyryshkin K. Endocr Relat Cancer. 2019 Jan 1;26(1):47-57. doi: 10.1530/ERC-18-0244. Endocr Relat Cancer. 2019. PMID: 30021866
Response to Letter to the Editor (Mangioni et al).
Maslove DM, Shapira T, Tyryshkin K, Veldhoen RA, Marshall JC, Muscedere J. Maslove DM, et al. Among authors: Tyryshkin K. J Crit Care. 2019 Aug;52:269. doi: 10.1016/j.jcrc.2019.03.004. Epub 2019 Mar 20. J Crit Care. 2019. PMID: 30922781 No abstract available.
Plasma microRNA expression levels and their targeted pathways in patients with major depressive disorder who are responsive to duloxetine treatment.
Kim HK, Tyryshkin K, Elmi N, Dharsee M, Evans KR, Good J, Javadi M, McCormack S, Vaccarino AL, Zhang X, Andreazza AC, Feilotter H. Kim HK, et al. Among authors: Tyryshkin K. J Psychiatr Res. 2019 Mar;110:38-44. doi: 10.1016/j.jpsychires.2018.12.007. Epub 2018 Dec 8. J Psychiatr Res. 2019. PMID: 30580082 Clinical Trial.
Genetic fitness and selection intensity in a population affected with high-incidence spinocerebellar ataxia type 1.
Platonov FA, Tyryshkin K, Tikhonov DG, Neustroyeva TS, Sivtseva TM, Yakovleva NV, Nikolaev VP, Sidorova OG, Kononova SK, Goldfarb LG, Renwick NM. Platonov FA, et al. Among authors: Tyryshkin K. Neurogenetics. 2016 Jul;17(3):179-85. doi: 10.1007/s10048-016-0481-5. Epub 2016 Apr 22. Neurogenetics. 2016. PMID: 27106293 Free PMC article.
17 results
Jump to page
Feedback